v3.25.0.1
SHAREHOLDERS' EQUITY (Details Textual)
 1 Months Ended 9 Months Ended 12 Months Ended
Mar. 15, 2024
shares
Sep. 27, 2021
₪ / shares
shares
Feb. 19, 2021
₪ / shares
shares
Feb. 19, 2021
₪ / shares
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2023
$ / shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2015
$ / shares
Sep. 30, 2024
₪ / shares
Sep. 30, 2024
USD ($)
shares
Dec. 31, 2023
₪ / shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
₪ / shares
shares
Dec. 22, 2022
USD ($)
Jul. 21, 2022
USD ($)
Jun. 02, 2022
₪ / shares
Jun. 02, 2022
USD ($)
$ / shares
Sep. 27, 2021
$ / shares
shares
Feb. 19, 2021
$ / shares
shares
Dec. 28, 2016
USD ($)
Shareholders' Equity                                            
Reverse share split, description         a reverse share split within a range of 1:2 to 1:12, to be effective at the ratio                                  
Maximum number of authorized ordinary shares reverse share split         120,000,000                                  
Issued and outstanding ordinary shares of reverse pre-split shares 60,100,000                                          
Issued and outstanding ordinary shares of reverse post-split shares 8,600,000                                          
Authorized number ordinary shares of reverse post-split shares 25,000,000                                          
Number of share-based outstanding                           33,171 43,994              
Warrants to purchase ordinary shares             32,895                              
Warrants outstanding                       2,498,574   19,187,375                
Total number of warrants outstanding                           9,814,754                
Options granted (in shares)         0   0                              
Proceeds from warrants | $             $ 13,800,000                              
Per share value of stock repurchase authorized | ₪ / shares                         ₪ 0.25   ₪ 0.25              
Ordinary shares, par value per share after reverse stock split | ₪ / shares                     ₪ 1.75   ₪ 1.75                  
Treasury Stock, Common, Shares                           4,022,607 2,933,208              
Private Placement [Member]                                            
Shareholders' Equity                                            
Issuance expenses | $             $ 3,679,000                              
Purchase agreement with certain institutional investors [Member]                                            
Shareholders' Equity                                            
Exercise price per share | $ / shares                                       $ 2    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   8,006,759                                   8,006,759    
Description of underwriting agreement   The Pre-Funded Warrants have an exercise price of $0.001 per Ordinary Share and are immediately exercisable and can be exercised at any time after their original issuance until such pre-funded warrants are exercised in full. Each ordinary shares was sold at an offering price of $2.035 and each pre-funded warrant was sold at an offering price of $2.034 (equal to the purchase price per ordinary share minus the exercise price of the pre-funded warrant).                                        
Issuance of ordinary shares (in shares)   15,403,014                                        
Per share value of stock repurchase authorized | ₪ / shares   ₪ 0.25                                        
Purchase agreement with certain institutional investors [Member] | Additionally Warrants Issued [Member]                                            
Shareholders' Equity                                            
Exercise price per share | $ / shares                                       $ 2.5438    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   960,811                                   960,811    
Issuance of ordinary shares (in shares)   610,504                                        
Purchase Agreement With Certain Institutional Accerdited Investors Member                                            
Shareholders' Equity                                            
Exercise price per share | $ / shares                                         $ 3.6  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     5,460,751 5,460,751                                 5,460,751  
Warrants exercisable, description     exercisable from February 19, 2021, until August 26, 2026                                      
Issuance of ordinary shares (in shares)       10,921,502                                    
Shares issued price per share | $ / shares                                         $ 3.6625  
Per share value of stock repurchase authorized | ₪ / shares     ₪ 0.25 ₪ 0.25                                    
Purchase Agreement With Certain Institutional Accerdited Investors Member | Additionally Warrants Issued [Member]                                            
Shareholders' Equity                                            
Exercise price per share | $ / shares                                         $ 4.578125  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     655,290 655,290                                 655,290  
Warrants exercisable, description     exercisable from February 19, 2021, until August 26, 2026                                      
Minimum [Member]                                            
Shareholders' Equity                                            
Authorized number ordinary shares of reverse post-split shares 30,000,000                                          
Exercise price per share | $ / shares                           $ 1.25                
Maximum [Member]                                            
Shareholders' Equity                                            
Authorized number ordinary shares of reverse post-split shares 43,750,000                                          
Exercise price per share | $ / shares                           $ 1.79                
Certain institutional purchasers [Member] | Offering of ordinary shares in February 2020 [Member]                                            
Shareholders' Equity                                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                       534,300     3,740,100              
Proceeds from warrants | $         $ 4,675,125     $ 4,675,125                            
Certain institutional purchasers [Member] | Offering of ordinary shares in February 2020 Two [Member]                                            
Shareholders' Equity                                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                             230,160              
Proceeds from warrants | $               359,625                            
Certain institutional purchasers [Member] | Registered direct offering of ordinary shares in July 2020 [Member]                                            
Shareholders' Equity                                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                       288,634                    
Proceeds from warrants | $         3,556,976                                  
Certain institutional purchasers [Member] | Offering of ordinary shares in July 2020 [Member]                                            
Shareholders' Equity                                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                             2,020,441              
Proceeds from warrants | $               3,555,976                            
Certain institutional purchasers [Member] | Offering of ordinary shares in December 2020 [Member]                                            
Shareholders' Equity                                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                       514,010                    
Proceeds from warrants | $         4,821,416                                  
Certain institutional purchasers [Member] | Offering of ordinary shares in December 2020 [Member]                                            
Shareholders' Equity                                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                             3,598,072              
Proceeds from warrants | $               4,821,416                            
Certain institutional purchasers [Member] | December 2020 private placement [Member]                                            
Shareholders' Equity                                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                             225,981              
Proceeds from warrants | $               405,003                            
Placement agent [Member] | February 2020 best efforts offering [Member]                                            
Shareholders' Equity                                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                       32,880                    
Proceeds from warrants | $         359,625                                  
Placement agent [Member] | December 2020 private placement [Member]                                            
Shareholders' Equity                                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                       32,283                    
Proceeds from warrants | $         $ 405,003                                  
Kreos Capital V [Member]                                            
Shareholders' Equity                                            
Warrants grant date                   Dec. 31, 2015                        
Warrants exercisable, description         currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company’s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of September 30, 2024.         currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company’s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2023.                        
Kreos Capital [Member]                                            
Shareholders' Equity                                            
Exercise price per share | $ / shares                   $ 52.5                        
Exercise price per share | $ / shares                   $ 7.5                        
Drawdown amount under loan agreement | $                                           $ 8,000,000
Employees, directors, officers, and non-employees [Member]                                            
Shareholders' Equity                                            
Shares reserved for future issuance (in shares)                           1,018,945 2,934,679              
Share-Based Payment Arrangement, Option [Member]                                            
Shareholders' Equity                                            
Award vesting period, description         Options to purchase ordinary shares generally vest over four years, with certain options to non-employee directors vesting quarterly over one year.                                  
Shares reserved for future issuance (in shares)                       0   145,560                
Unrecognized cost of shares | $                       $ 1,700,000   $ 2,700,000                
Expected term of shares         2 years 3 months 18 days   2 years 10 months 24 days                              
Total fair value of shares vested | $             $ 1,268,000 $ 860,000 $ 802,000                          
Restricted Stock Units (RSUs) [Member]                                            
Shareholders' Equity                                            
Weighted average grant date fair value, restricted stock units (in USD per share) | $ / shares             $ 0.66 $ 1 $ 1.69                          
Weighted average grant date fair value, options (in USD per share) | $ / shares         $ 4.8 $ 4.69                                
Restricted Stock Units (RSUs) [Member] | Nonemployee [Member]                                            
Shareholders' Equity                                            
Number of share-based outstanding                       0                    
Outstanding RSUs                           21,929                
Share Repurchase Program [Member]                                            
Shareholders' Equity                                            
Number of ordinary shares repurchased, amount | $                               $ 5,800,000 $ 8,000,000   $ 8,000,000      
Outstanding ordinary shares repurchased, shares                           4,022,607                
Shares issued price per share | ₪ / shares                                   ₪ 0.25        
Issuance expenses | $             $ 3,500,000                              
Per share value of stock repurchase authorized | $ / shares                                     $ 0.25      
Treasury Stock, Common, Shares                       574,658                    
Total cost | $         $ 3,500,000